contained no protein, or a trace only, there were no abnormal deposits, and culture was sterile. Erythrocyte sedimentation rate 7 mm./hr., Hb 16-6 g. per cent.; white cells 7,000; serum albumin 3.9 g./100 ml.
Chest x ray showed a slightly enlarged left ventricle. Intravenous pyelogram was normal.
Treatment.-He was given probenecid 1-0 g., colchicine 1X0 mg., and sodium bicarbonate 6-0 g. daily.
*Present address: Charing Cross Hospital, London, W.C.2. tPressnt address: The London Hospital, London E.1.
Progress.-In April, 1963, he was feeling well but the serum uric acid remained elevated at 10-0 mg./100 ml. The blood urea was 96 mg./100 ml. The urine contained a trace of protein. The same treatment was continued.
In July, 1963 , there was the onset of swelling of both legs which persisted over the following month. In October there was an episode of pain and tenderness in the right calf. The patient was re-admitted to Hammersmith Hospital in December, 1963, with gross oedema of the legs. Jugular venous pressure was slightly raised at 1 cm. and the heart was slightly enlarged as before, but physical examination was otherwise negative.
The blood-pressure was 120/70. Serum uric acid 9 mg./100 ml., blood urea 76 mg./100 ml. There was now heavy albuminuria (23 g./24 hrs) but no other abnormality in the urine. The serum albumin had fallen to 1 6 g. per cent.; serum cholesterol 490 mg./ 100 ml. Erythrocyte sedimentation rate 100 mm./hr; Hb 12*6 g. per cent; white cells 4,000.
The chest x ray was unchanged; an electrocardiogram showed changes consistent with mild ischaemia.
Renal biopsy (Dr. E. K. M. Smith) showed a few foci of tubular atrophy and fibrosis (Fig. 1, overleaf) . Crystal spaces were not seen. Examination for amyloid using Congo red staining and crossed polaroids was negative.
On January 3, 1964, probenecid was discontinued. The serum uric acid rose to 12 mg./100 ml. and a few days later the patient had an acute attack of gout in the right knee. During the next 3 weeks, however, the oedema subsided, his weight fell from 102 to 88 kg., albuminuria decreased to 1 * 5 g./24 hrs, the serum albumin rose to 3 -3 g./100 ml., and the serum cholesterol fell to 250 mg./100 ml.
On January 27 treatment was commenced with allopurinol and colchicine.* Since then he has done well; he has been free of acute gout and chronic joint pain, the tophi are receding, serum uric acid 4'1 mg./ 100 ml., blood urea 87 mg./100 ml. (January, 1967) . There has been no recurrence of oedema, and no more than a trace of proteinuria. *This aspect of the case has already been reported in detail (Hall, Holloway, and Scott, 1964; Case 1 also in the interstitial tissues of the medulla. In addition there was marked oedema of the interstitial tissue of both cortex and medulla on both sides, which accounted for the increased weight of the kidneys. The glomeruli showed no abnormality on light microscopy. Examination for amyloid was negative.
Discussion
There have been two previous reports of nephrotic syndrome apparently caused by probenecid. Ferris, Morgan, and Levitin (1961) described the case of a man with gout who within 4 months of starting treatment with probenecid developed oedema, which disappeared when the drug was stopped. Probenecid was recommenced on two subsequent occasions, and on each he again became oedematous, with proteinuria and hypoalbuminaemia, recovery following withdrawal of the drug. Sokol, Bashner, and Okun (1967) described a similar patient who developed the nephrotic syndrome 3 months after starting probenecid. Recovery followed withdrawal, and the same sequence was repeated when a further attempt was made to administer the drug. Renal biopsy carried out during the first recovery phase showed no abnormality apart from precipitated protein in Bowman's spaces and in the convoluted tubules.
It is conceded that the evidence associating the development of oedema and proteinuria with the D use of probenecid in our two patients is by no means conclusive. Case 1 was known to have pre-existing chronic impairment of kidney function although there was no history of any disease other than gout. The transient episode of calf tenderness which occurred 3 months after the onset of oedema was diagnosed as leg vein thrombosis and raised the possibility that the nephrotic syndrome was due to venous thrombosis involving the inferior vena cava and renal veins. The improvement which followed withdrawal of probenecid, however, was striking and sustained. The clinical picture in Case 2 differed from that in Case 1 in that, although there was severe oedema and heavy proteinuria, the serum albumin was not lowered (cholesterol was not estimated) and renal failure led to death. The urine was infected during the terminal illness but there was no previous evidence of urinary infection or of kidney disease. The intervals between starting probenecid therapy and the onset of oedema were 8 and 15 months in the two patients, which is considerably longer than those in the other two reports. Both patients were also taking maintenance colchicine therapy, but this drug has never been noted to cause renal damage and Case 1 subsequently took colchicine (with allopurinol) over a prolonged period with no recurrence of oedema or proteinuria. Finally, the appearance of the renal histology was dissimilar in the two patients, the extensive bilateral tubular changes seen in the second case having no counterpart in the first. Brown and Mallory (1950) record tubular atrophy and dilatation, both focal and generalized, as a finding in the gouty kidney, though none of their cases had generalized oedema or large pale kidneys, and all showed other renal complications such as nephrosclerosis or pyelonephritis.
Proteinuria and renal failure are seen to develop in a number of patients with gout (Talbott and Terplan, 1960) Probenecid, sindrome nefr6tico e insuficiencia renal SUMARIO Dos enfermos con gota presentaron un edema y una proteinuria 8 y 15 meses despues de empezar tratamiento con probenecid. Uno de ellos recobr6 rapidamente de un sindrome nefrotico clasico despues de parar el tratamiento, pero el otro, que seguia tomando el probenecid, muri6 de insificiencia renal. Se discute la posibilidad de una asociacion causal. 
